Ntl. Reference Centre Mammography Munich, SonnenStr. 29, D 80331 Munich, Germany.
Breast. 2013 Aug;22 Suppl 2:S77-82. doi: 10.1016/j.breast.2013.07.014.
To provide an overview of the principle of current breast MRI, the available evidence concerning its indications and optimum use and future potentials.
To date sensitivities of 90-91% have been achieved with a specificity of 72-75%. MRI is the most sensitive method for detecting invasive carcinoma and comparable to mammography concerning detection of DCIS. The achievable specificity, false positive and biopsy rates, however, are much lower than for screening mammography thus do not allow its use for screening of the general population. Indications with proven advantages concern screening of women at high risk and special diagnostic problems that cannot be solved by conventional imaging and percutaneous biopsy: search for primary tumour in CUP syndrome, differentiation of nipple retraction, differentiation of scarring versus recurrence and selected difficult cases. There is no proven benefit for its general use for preoperative staging. One major problem may concern the imperfect interface between imaging and surgery. Further research is also needed for the use of MRI in women at intermediate risk. In women at low risk MRI screening is not recommended. Novel possibilities of MRI concern diffusion weighted imaging as well as MR spectroscopy. Their value for improved lesion differentiation is not yet fully established. Their main potential appears to concern an improved and earlier prediction of response to neoadjuvant therapy. Future developments might address development of more specific contrast agents, replacement of vascular enhancing agents by special MR techniques, testing of sodium MRI or image fusion with other imaging modalities.
DISCUSSION/CONCLUSION: MRI allows new patho-physiological information and thus can complement the information available by conventional methods. Present research should concentrate on improving specificity, improving the interface of imaging and surgery and has to include outcome analyses. Due to issues of specificity the responsible use of MRI should be limited to appropriate indications.
提供当前乳腺 MRI 的原理概述,关于其适应证和最佳应用的现有证据以及未来潜力。
迄今为止,其灵敏度已达到 90-91%,特异性为 72-75%。MRI 是检测浸润性癌的最敏感方法,在检测 DCIS 方面与乳房 X 线摄影相当。然而,可实现的特异性、假阳性和活检率要低得多,远低于筛查性乳房 X 线摄影,因此不能将其用于普通人群的筛查。具有明确优势的适应证包括高危女性的筛查和常规成像和经皮活检无法解决的特殊诊断问题:寻找 CUP 综合征中的原发性肿瘤、乳头回缩的鉴别、瘢痕与复发的鉴别以及选定的疑难病例。对于一般人群的术前分期,其一般使用没有被证明有获益。一个主要问题可能涉及成像与手术之间的不完美界面。还需要进一步研究 MRI 在中危女性中的应用。对于低危女性,不建议进行 MRI 筛查。MRI 的新可能性包括扩散加权成像以及磁共振波谱。其用于改善病变分化的价值尚未完全确立。其主要潜力似乎在于改善和更早地预测新辅助治疗的反应。未来的发展可能涉及开发更具特异性的对比剂、用特殊的磁共振技术替代血管增强剂、测试钠 MRI 或与其他成像方式的图像融合。
讨论/结论:MRI 可以提供新的病理生理信息,从而可以补充常规方法提供的信息。目前的研究应集中在提高特异性、改善成像与手术的界面以及包括结果分析上。由于特异性问题,MRI 的合理使用应限于适当的适应证。